| Name | Title | Contact Details |
|---|
Our number one priority is successfully creating and providing essential services and support for limited companies in the UK. Our straightforward process can have your company set up in a matter of hours!
Atlas Copco Group enables technology that transforms the future. We innovate to develop products, services and solutions that are key to our customers success. Our four business areas offer compressed air and vacuum solutions, energy solutions, dewatering and industrial pumps, industrial power tools and assembly and machine vision solutions. In 2023, the Group had revenues of BSEK 173, and at year end about 53 000 employees.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Smoothie King is a global health-focused smoothie company founded in 1973 in Kenner, Louisiana. It pioneered the smoothie sales concept and has grown to become a leading brand in the industry. The company was acquired in 2012 by Wan Kim, who expanded its reach and offerings. Smoothie King operates over 1,000 locations worldwide, with its headquarters in Dallas, Texas. The company offers a diverse menu of smoothies made from non-GMO fruits and vegetables, catering to various nutritional goals such as weight management, energy boosts, and muscle recovery. In addition to smoothies, some locations provide sports beverages, energy bars, snacks, and vitamin supplements. Smoothie Kings mission is to promote health and wellness by delivering high-quality, nutritious products while emphasizing ingredient transparency.